Clinical analysis of the recombinant human growth hormone combined with letrozole in the treatment of short pubertal boys
- Author:
Ying ZHANG
1
;
Rui-min CHEN
1
;
Xiao-hong YANG
1
Author Information
- Publication Type:Journal Article
- Keywords: letrozole; short stature; puberty; recombinant human growth hormone
- From: Chinese Journal of Practical Pediatrics 2019;34(09):775-779
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To explore the therapeutic effects and adverse reactions of a combination treatment of recombinant human growth hormone(rh GH)with letrozole,compared with rh GH alone,in short pubertal boys. METHODS: Fifty-five short pubertal boys were divided into two groups,one group was treated with rh GH(rh GH group,n=24),and the other group was treated with the combination of rh GH and letrozole(combination group,n=31). All boys had completed the over one year of treatment. The advancement of bone age(BA),height standard deviation score by bone age(Ht SDSBA),body mass index standard deviation(BMI SDS),glucose and lipid metabolism,and the changes of the external genitalia and adverse reactions were evaluated. RESULTS: The age of two groups was(12.72±0.99)years and(12.90±1.36)years,respectively(P>0.05).The treatment periods were(1.71±0.55)years and(1.58±0.46)years,respectively(P>0.05).Their BA increased(0.96±0.27)years/year and(0.50±0.20)years/year during treatment,respectively(P<0.01). Their Ht SDSBAincreased(0.89±0.50)and(1.22±0.42)(P<0.01)and testicular size increased(7.47±3.41)m L and(9.50±3.12)m L(P>0.05)respectively during treatment. There were no statistically significant difference in BMI SDS,glucose or lipid metabolism between the two groups.Three boys in combination group suffered from fractures during the treatment. Ultrasound bone density scan showed serious shortage of bone mineral density;after supplemental calcium and calcitriol,bone density increased within 3 to 6 months,and there was no recurrence of fracture. CONCLUSION: Combination of rh GH and letrozole in short pubertal boys could inhibit BA progression and ameliorate HtSDSBA,without affecting the normal sexual development,but bone density may be affected,and long-term follow-up is needed.
